{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-24-006160","form_type":"8-K","ticker":"UG","cik":"0000101295","company_name":"UNITED GUARDIAN INC","filed_at":"2024-11-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.362198+00:00","generated_at":"2026-05-30T02:38:46.317444+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"United-Guardian Q3 net income up to $0.19/share; nine-month sales +17%","bullets":["Nine-month 2024 sales $9.7M (+17% YoY); net income $2.7M ($0.60/share) vs $1.8M ($0.40/share) in 2023.","Q3 sales steady at $3.06M; net income $865K ($0.19/share) up from $627K ($0.14/share).","Cosmetic ingredient sales surged 68% in nine months, driven by largest distributor.","Medical lubricant sales +4% over nine months; pharmaceutical sales -11% due to Renacidin supply disruption.","President expects continued recovery from Renacidin supply shutdown."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-24-006160","json":"https://secwatch.observer/filing/0001171843-24-006160.json","markdown":"https://secwatch.observer/filing/0001171843-24-006160.md","text":"https://secwatch.observer/filing/0001171843-24-006160.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/101295/000117184324006160/0001171843-24-006160-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/101295/000117184324006160/f8k_110724.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T02:38:46.317444+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}